An engineered three-phase biomaterial scaffold successfully recreated the cranial suture stem cell niche lost in craniosynostosis, a condition that causes premature fusion of the skull bones. Using a pore size-dependent “bone-suture-bone” design, this scaffold maintained skeletal stem cells while supporting surrounding bone formation. In mouse models, this construct prevented refusion, restored craniofacial growth, and improved skull morphology. This discovery could advance regenerative therapies that directly address the underlying causes of pediatric craniofacial disorders.
Craniosynostosis is a congenital disorder in which one or more fibrous joints between the skulls fuse together prematurely during development. The disease, which affects 1 in 2,500 births, limits the normal growth of the brain and skull and can cause abnormal head shape, increased intracranial pressure, developmental complications, and repeated surgeries. Current treatments rely on invasive procedures that reopen or reshape the skull, but many patients experience reunion of surgical sutures, highlighting the need for safer and more durable solutions.
The research team tackling this issue was led by Professor Yuji Mishina of the Department of Biomaterial Sciences, School of Dentistry, University of Michigan, USA, and Dr. W. Benton Swanson, Department of Oral Medicine, Infection, and Immunology, Harvard University School of Dentistry, USA. The research team focused on the underlying biological causes of craniosynostosis: the loss of skeletal stem cells that normally reside within the cranial sutures and direct cranial growth. They developed a regenerative strategy that rebuilds the stem cell niche itself, rather than simply blocking bone formation. Their findings were published in Volume 14 of the journal. bone research May 28, 2026.
Researchers designed a biodegradable three-phase scaffold from poly(L-lactic acid), an FDA-approved biomaterial used in multiple medical applications. Inspired by the natural “bone-suture-bone” structure of the skull, this scaffold contains three interconnected compartments with different pore sizes. The small pore area in the center is designed to maintain stem cell properties, while the larger pores on both sides promote angiogenesis and bone formation. Together, these compartments created a microenvironment that could sustain stem cells while supporting normal skeletal development.
Experiments showed that the scaffold actively guided cell behavior. Skeletal stem cells located within the central compartment retained stem cell-like characteristics, while cells that began to differentiate migrated to adjacent regions and contributed to bone formation. This design also produced a distinct pattern of blood vessel growth and extracellular matrix organization that closely resembles that seen in native cranial sutures. Lineage tracing studies further demonstrated that the scaffold maintains a reservoir of stem cells while allowing their progeny to participate in tissue regeneration.
To determine whether this construct could withstand disease-promoting signals, the research team challenged excessive bone morphogenetic protein activity, a pathway associated with abnormal bone formation. Even under these conditions, the central compartment resisted ossification and preserved the nonosteoblast niche. This finding suggested that the engineered microenvironment may be able to counteract the biological processes that normally cause premature suture union.
This scaffold was then tested in a mouse model of median craniosynostosis, which closely resembles the most common non-syndromic form in humans. After surgically removing the fused sutures, the researchers implanted a scaffold into the defect. Whereas animals receiving conventional treatment experienced reunion, animals receiving the triphasic scaffold maintained open suture-like tissue and had significantly improved craniofacial growth. Early interventions produced the strongest benefits, highlighting the importance of restoring normal growth patterns during critical developmental periods.
“Our goal was not simply to reopen the fused sutures, but to regenerate a biological niche that allows the skull to grow normally.” said Professor Mishina. “By re-establishing the environment that sustains skeletal stem cells, we were able to steer craniofacial development onto a healthier trajectory.”
Dr. Swanson added:This study demonstrates how rational biomaterial design can simultaneously control stem cell fate and tissue organization. We believe that the principles established here have the potential to be broadly applicable to regenerative therapies beyond craniosynostosis. ”
Overall, this study demonstrates that reconstitution of the stem cell niche can be a powerful therapeutic strategy. By combining developmental biology and tissue engineering, the team created a biomaterial scaffold that can preserve skeletal stem cells, prevent pathological bone fusion, and restore more normal skull growth. This finding provides a framework for manipulating functional stem cell niches that may extend beyond craniosynostosis and ultimately support regenerative treatments for other skeletal diseases and developmental conditions.
sauce:
Reference magazines:
WB Swanson Others. (2026). A tissue engineering approach to regenerating cranial suture skeletal stem cell niches using multicompartmental biomaterial scaffolds. bone research. DOI: 10.1038/s41413-026-00539-z. https://www.nature.com/articles/s41413-026-00539-z
